8TH INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES

支持是要求允许20名年轻的美国调查人员在传染病 参加第八届国际传染病大会 （排灌委员会）定于1998年5月15日至18日在波士顿举行。 国会带来了 来自100个国家的5，000多名与会者聚集在一起， 一系列微生物学科学和临床进展， 传染病 除了允许年轻的美国调查人员见面 并与国际知名的调查人员互动，第八届ICID 在国际传染病会议中独一无二，吸引了 来自发展中国家的医生和科学家广泛参与 国家 《2000年健康人》的目标包括减少 结核病，人类免疫缺陷病毒，疫苗可预防 预防新的传染病的出现 实现这些目标越来越需要国际社会 努力与合作。 这方面的例子包括为解决日益严重的 外国出生的美国结核病病例和国际艾滋病毒感染者的百分比 疫苗试验 此外，资源贫乏的国家首当其冲， 新发和再发传染病的发病率和死亡率 疾病 与当地同事在这些国家进行的调查将 美国调查人员必须参与了解 控制这些疾病。 早期的艾滋病研究 非洲中心最近在加蓬对埃博拉病毒的研究， 疾病控制和预防，以及正在进行的合作，包括 美国和南美的调查人员了解了 耐抗生素肺炎链球菌的流行病学 这些关系的重要性的例子。 第八届ICID将 帮助年轻的美国调查人员建立联系和关系， 这些国际努力是必要的。 临床研讨会 治疗更新，传统和分子流行病学的进展， 感染控制实践、免疫学和分子生物学的发展 将包括遗传学和微生物学。 节目内容为 由国际知名传染病委员会监督 医生和科学家。 委员会和国会都是 国际传染病学会的责任 （ISID）第八届ICID由传染病联合会共同主办， 美国社会和钱宁实验室，一个部门， 布里格姆妇女医院医学部和哈佛医学院 学校 该计划的部分预计将被认可为 继续医学教育学分。

Support is request to permit 20 young US investigators in infectious diseases to attend the 8th International Congress for Infectious Disease (ICID) to be held in Boston from May 15-18 1998. The Congress brings together over 5,000 participants from 100 countries to discuss the spectrum of scientific and clinical advances in microbiology and infectious diseases. Besides allowing young US investigators to meet and to interact with internationally known investigators, the 8th ICID is unique among international infectious disease meetings in attracting broad participation from physicians and scientists from developing countries. Goals of Healthy People 2000 include the reduction of tuberculosis, human immunodeficiency virus, vaccine preventable diseases, and the prevention of the emergence of new infectious diseases, Achieving these goals increasingly requires international efforts and cooperation. Examples include studies to address the rising percentage of foreign-born US tuberculosis cases and international HIV vaccine trials. Furthermore, resource poor countries bear the brunt of morbidity and mortality from emerging and re-emerging infectious diseases. Investigations in these countries with local colleagues will be essential for US investigators to be involved in the understanding and control of these diseases. The early studies of HIV throughout Africa, the recent work on Ebola virus in Gabon by the Centers for Disease control and Prevention, and the ongoing collaborations involving US and South American investigators to understand the molecular epidemiology of antibiotic resistant Streptococcus pneumoniae are examples of the importance of these relationships. The 8th ICID will help young US investigators develop the contacts and relationships necessary for these international efforts. Symposia on clinical treatment updates, advances in traditional and molecular epidemiology, infection control practices, developments in immunology and molecular genetics and microbiology will be included. The program content is overseen by a committee of internationally known infectious disease physicians and scientists. Both the Committee and the Congress are the responsibility of the International Society for Infectious Diseases (ISID) The 8th ICID is being co-sponsored by the Infectious Diseases Society of America and the Channing laboratory, a division of the Brigham and Women's Hospital Department of Medicine and Harvard Medical School. Portions of the program are expected to be accredited for continuing medical education credits.